Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shozo Nishida

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
British Journal of Pharmacology|March 6, 2002
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretionNaoyuki Kawao, Yuriko Sakaguchi, Ai Tagome, et al.
Journal of Cellular Biochemistry|November 6, 2010
Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathwayMasanobu Tsubaki, Chisato Kato, Ai Isono, et al.
American Journal of Cancer Research|December 23, 2015
Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma modelMasanobu Tsubaki, Tomoya Takeda, Toshiki Kino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey]Katsumasa Tsurushima, Yukiko Yanagishita, Naoki Ogawa, et al.
Chemico-Biological Interactions|March 22, 2016
Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinaseTomoya Takeda, Masanobu Tsubaki, Toshiki Kino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
[Clinical evaluation of calculating carboplatin dosage using Japanese equation for estimating GFR for gynecologic cancer]Yasuhiro Kidera, Masahiko Nakao, Masanobu Tsubaki, et al.
Molecular and Cellular Biochemistry|June 6, 2007
Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathwaysMasanobu Tsubaki, Chisato Kato, Miyuki Manno, et al.
Leukemia Research|March 2, 2015
Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cellsMasanobu Tsubaki, Tomoya Takeda, Naoki Ogawa, et al.
Molecular and Cellular Biochemistry|November 25, 2024
Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS/ERK/NF-κB pathway in KRAS-mutated colon cancer cellsTadafumi Hoshida, Masanobu Tsubaki, Tomoya Takeda, et al.
Journal of Cellular Physiology|October 24, 2017
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugsMasanobu Tsubaki, Tomoya Takeda, Yoshika Tomonari, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
British Journal of Pharmacology|March 6, 2002
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretionNaoyuki Kawao, Yuriko Sakaguchi, Ai Tagome, et al.
Journal of Cellular Biochemistry|November 6, 2010
Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathwayMasanobu Tsubaki, Chisato Kato, Ai Isono, et al.
American Journal of Cancer Research|December 23, 2015
Statins improve survival by inhibiting spontaneous metastasis and tumor growth in a mouse melanoma modelMasanobu Tsubaki, Tomoya Takeda, Toshiki Kino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey]Katsumasa Tsurushima, Yukiko Yanagishita, Naoki Ogawa, et al.
Chemico-Biological Interactions|March 22, 2016
Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinaseTomoya Takeda, Masanobu Tsubaki, Toshiki Kino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
[Clinical evaluation of calculating carboplatin dosage using Japanese equation for estimating GFR for gynecologic cancer]Yasuhiro Kidera, Masahiko Nakao, Masanobu Tsubaki, et al.
Molecular and Cellular Biochemistry|June 6, 2007
Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathwaysMasanobu Tsubaki, Chisato Kato, Miyuki Manno, et al.
Leukemia Research|March 2, 2015
Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cellsMasanobu Tsubaki, Tomoya Takeda, Naoki Ogawa, et al.
Molecular and Cellular Biochemistry|November 25, 2024
Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS/ERK/NF-κB pathway in KRAS-mutated colon cancer cellsTadafumi Hoshida, Masanobu Tsubaki, Tomoya Takeda, et al.
Journal of Cellular Physiology|October 24, 2017
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugsMasanobu Tsubaki, Tomoya Takeda, Yoshika Tomonari, et al.
Pageof 13